WASHINGTON: A limited emergency-use authorisation for two anti-malarial drugs touted as gamechangers by President Donald Trump has been issued by the US Food and Drug Administration to treat coronavirus patients.
In a statement published Sunday (Mar 29), the US Department of Health and Human Services detailed recent donations of medicine to a national stockpile - including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.